Come up with a name for your new list and we'll add to it:
VBI Vaccines raised a round of funding on , . Investors include
ARCH Venture Partners.
VBI Vaccines (NASDAQ: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI's eVLP vaccine platform allows for the…